R. Leake

发表

A Sensitive and Robust Assay for Urokinase and Tissue-Type Plasminogen Activators (Upa and Tpa) and Their Inhibitor Type I (Pai-1) in Breast Tumor Cytosols

A. Geurts-Moespot, J. Heuvel, T. Benraad, 1997, The International journal of biological markers.

Detection of the oestrogen receptor (ER). immunohistochemical versus cytosol measurements.

R. Leake, 2000, European journal of cancer.

Quality control for the immunohistochemical demonstration of oestrogen and progesterone receptors

R. Nicholson, R. Leake, 2000, Journal of clinical pathology.

Epidermal growth factor receptor in normal ovaries and benign ovarian tumours.

R. Leake, O. Owens, 1992, European journal of obstetrics, gynecology, and reproductive biology.

Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): report of an EORTC/BIOMED-1 workshop.

N. Brünner, J. Foekens, C. Sweep, 1996, European journal of cancer.

A multicentre study into the reliability of steroid receptor immunocytochemical assay quantification. British Quality Control Group.

R. Nicholson, R. McClelland, D. Wilson, 1991, European journal of cancer.

Molecular aspects of the GM-CSF receptor: an example of the cell signalling mechanisms used by type 1 cytokine receptors.

R. Leake, 1999, European journal of cancer.

Growth factor content in normal and benign ovarian tumours.

R. Leake, R. Leake, O. Owens, 1992, European journal of obstetrics, gynecology, and reproductive biology.

Serum hormone levels in breast cancer patients and controls in Egypt and Great Britain. The Anglo-Egyptian Health Agreement Collaborative Study.

G. Clark, R. Rubens, J. Hayward, 1988, European journal of cancer & clinical oncology.

Human monoclonal antibodies and monoclonal antibody multispecificity.

A. Campbell, R. Leake, A. Campbell, 1987, British Journal of Cancer.

Inhibition of the TGF- mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor

J. Smyth, R. Leake, W. Miller, 2018 .

A comparison of biochemical and immunohistochemical assessment of EGFR expression in ovarian cancer.

A. Mcnicol, R. Leake, O. Owens, 1992, Anticancer research.

Growth factors in ovarian cancer.

R. Leake, O. Owens, C. Stewart, 1991, British Journal of Cancer.

Measurement of oestradiol receptors by five institutions on common tissue samples.

D. Barnes, R. King, R. Leake, 1978, British Journal of Cancer.

Measurement of steroid hormone concentrations in blood, urine and tissues

G. Beastall, R. Leake, B. Green, 1987 .

Epidermal growth factor receptors (EGFR) in human ovarian cancer.

R. Leake, O. Owens, I. Brown, 1991, British Journal of Cancer.

Twenty years of experience with the steroid receptor external quality assessment program - the paradigm for tumour biomarker EQA studies. On behalf of the EROTC Receptor and Biomarker Study Group.

C. Sweep, J. Geurts-Moespot, T. Benraad, 2000, International journal of oncology.

Transforming Growth Factor β1 Stimulates Urokinase Plasminogen Activator System on Prostate Cancer Cells

A. Unlu, R. Leake, R. Leake, 2003 .

The performance of a commercial radioligand binding assay for the epidermal growth factor receptor is comparable to the EORTC standard assay.

R. Zeillinger, A. Geurts-Moespot, T. Benraad, 1995, European journal of cancer.

Immunological analysis of the specificity of the autologous humoral response in breast cancer patients.

A. Campbell, R. Leake, W. Holton, 1986, British Journal of Cancer.

Carcinogenesis and Diet Restriction

R. Leake, O. Owens, C. Stewart, 1993, Environmental Health Perspectives.

High affinity binding of oestradiol-17 beta in the nuclei of human endometrial cells.

R. Leake, W. P. Soutter, K. Hamilton, 1979, Journal of steroid biochemistry.

Surgical reasearch society. Pre‐operative determination of oestrogen receptor status in breast cancer by immunocytochemical staining of fine needle aspirates

S. Cowan, R. Leake, R. Leake, 1985 .

Inhibition of transforming growth factor α (TGF-α)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868

J. Bartlett, J. Smyth, S. Langdon, 1999, British Journal of Cancer.

Epidermal growth-factor receptor expression in malignant ovary, benign ovarian-tumors and normal ovary - a comparison.

R. Leake, O. Owens, 1993, International Journal of Oncology.

Soluble and nuclear oestrogen receptor status of advanced endometrial cancer in relation to subsequent clinical prognosis.

L. Castagnetta, R. Leake, M. Ciaccio, 1987, British Journal of Cancer.

Immunological analysis of the specificity of the autologous humoral response in breast cancer patients.

R. Leake, A. Campbell, M. Mccormack, 1986, British Journal of Cancer.

Growth Factors in Human Ovarian Follicle Fluid and Growth Factor Receptors in Granulosa-Luteal Cells

R. Leake, J. Coutts, R. Mcwilliam, 1995, The International journal of biological markers.

Stability of oestrogen receptor status in sequential biopsies from patients with breast cancer.

D. Smith, R. Fitch, S. Cowan, 1987, British Journal of Cancer.

Oestrogen and progesterone receptors in carcinoma of the cervix.

N. Reed, J. Paul, M. Harding, 1990, Clinical oncology (Royal College of Radiologists (Great Britain)).